Quantitative ultrasound techniques and biochemical markers to assess liver steatosis and fibrosis in newly diagnosed acromegaly
Journal of Endocrinological Investigation · 2024
DOI: 10.1007/s40618-024-02384-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Endocrinological Investigation, 2024. Verfasst von M Coskun und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Faculty of Medicine, Gazi University, Ankara, Turkey. drmericcoskun@gmail.com. Hauptthemen laut MEDLINE: Acromegaly, Liver Cirrhosis, Biomarkers, Fatty Liver. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Endocrinology and Metabolism Training Coordination Association, Gazi University.
Abstract (Originalsprache)
Purpose
The liver is known to be protected from steatosis under the influence of high GH/IGF-1. Cytokeratin 18 (CK18) and insulin-like growth factor binding protein 7 (IGFBP7) increase in liver steatosis and fibrosis. The aim of this study was to use quantitative ultrasound techniques and biochemical markers to assess liver steatosis and liver fibrosis in newly diagnosed acromegaly.
Methods
This single-center, cross-sectional study included 23 patients with newly diagnosed acromegaly and 46 age, sex, body mass index (BMI) and waist circumference (WC)-matched controls. Liver steatosis was assessed using tissue attenuation imaging (TAI), and stiffness, indicative of fibrosis, was assessed by shear wave elastography (SWE). Serum IGFBP7 and CK18 were studied by ELISA.
Results
The acromegaly group had significantly lower liver steatosis (p = 0.006) and higher liver stiffness (p = 0.004), serum IGFBP7 (p = 0.048) and CK18 (p = 0.005) levels than the control group. The presence of fibrosis (p = 0.012) was significantly higher in the acromegaly group than in the control group. Moreover, CK18 was positively correlated with liver stiffness, WC, HOMA-IR, HbA1c, and triglyceride. In the acromegaly group, liver steatosis was negatively correlated with GH level. Stepwise multiple linear regression analysis revealed that BMI (p = 0.008) and CK18 (p = 0.015) were independent risk factors for increased liver stiffness.
Conclusion
This study showed that there was an increased presence of liver fibrosis independent of liver steatosis in newly diagnosed acromegaly. Serum CK18 appears to be a potential marker of increased liver fibrosis in acromegaly.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, Faculty of Medicine, Gazi University, Ankara, Turkey. drmericcoskun@gmail.com.
- Department of Radiology, Faculty of Medicine, Gazi University, 06100, Ankara, Turkey.
- Department of Endocrinology and Metabolism, Faculty of Medicine, Gazi University, Ankara, Turkey.
Förderung
- Endocrinology and Metabolism Training Coordination Association
- Gazi University
Zitieren
APA
Coskun, M., Sendur, H. N., Babayeva, A., Cerit, M. N., Cerit, E. T., Yalcin, M. M., Altinova, A. E., Akturk, M., Karakoc, M. A., & Toruner, F. B. (2024). Quantitative ultrasound techniques and biochemical markers to assess liver steatosis and fibrosis in newly diagnosed acromegaly. Journal of Endocrinological Investigation. https://doi.org/10.1007/s40618-024-02384-5
Vancouver
Coskun M, Sendur HN, Babayeva A, Cerit MN, Cerit ET, Yalcin MM, et al. Quantitative ultrasound techniques and biochemical markers to assess liver steatosis and fibrosis in newly diagnosed acromegaly. Journal of Endocrinological Investigation. 2024. doi:10.1007/s40618-024-02384-5
BibTeX
@article{Coskun2024,
author = {Coskun, M and Sendur, H N and Babayeva, A and Cerit, M N and Cerit, E T and Yalcin, M M and Altinova, A E and Akturk, M and Karakoc, M A and Toruner, F B},
title = {Quantitative ultrasound techniques and biochemical markers to assess liver steatosis and fibrosis in newly diagnosed acromegaly},
journal = {Journal of Endocrinological Investigation},
year = {2024},
doi = {10.1007/s40618-024-02384-5}
}
EUVIMED